Ameliorative effects of acetyl-L-carnitine on corpus callosum and functional recovery in demyelinated mouse model

References

• Vega-Riquer JM, Mendez-Victoriano G, Morales-Luckie RA, et al. Five decades of cuprizone, an updated model to replicate demyelinating diseases. Curr Neuropharmacol. 2019;17(2):129–141.
   PubMed Web of Science ®Google Scholar
• McGinley MP, Goldschmidt CH, Rae-Grant AD. Diagnosis and treatment of multiple sclerosis: a review. JAMA. 2021;325(8):765–779.
   PubMed Web of Science ®Google Scholar
• Nielsen S, Germanos R, Weier M, et al. The use of cannabis and cannabinoids in treating symptoms of multiple sclerosis: a systematic review of reviews. Curr Neurol Neurosci Rep. 2018;18(2):8–12.
   PubMed Web of Science ®Google Scholar
• Ransohoff RM. Animal models of multiple sclerosis: the good, the bad and the bottom line. Nat Neurosci. 2012;15(8):1074–1077.
   PubMed Web of Science ®Google Scholar
• Freedman DM, Dosemeci M, Alavanja MC. Mortality from multiple sclerosis and exposure to residential and occupational solar radiation: a case-control study based on death certificates. Occup Environ Med. 2000;57(6):418–421.
   PubMed Web of Science ®Google Scholar
• Lubetzki C, Zalc B, Williams A, et al. Remyelination in multiple sclerosis: from basic science to clinical translation. Lancet Neurol. 2020;19(8):678–688.
   PubMed Web of Science ®Google Scholar
• Lyczek A, Arnold A, Zhang J, et al. Transplanted human glial-restricted progenitors can rescue the survival of dysmyelinated mice independent of the production of mature, compact myelin. Exp Neurol. 2017;291:74–86.
   PubMed Web of Science ®Google Scholar
• Lassmann H. Multiple sclerosis: lessons from molecular neuropathology. Exp Neurol. 2014;262:2–7.
   PubMed Web of Science ®Google Scholar
• Lau LW, Cua R, Keough MB, et al. Pathophysiology of the brain extracellular matrix: a new target for remyelination. Nat Rev Neurosci. 2013;14(10):722–729.
   PubMed Web of Science ®Google Scholar
• Kuhlmann T, Ludwin S, Prat A, et al. An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol. 2017;133(1):13–24.
   PubMed Web of Science ®Google Scholar
• Lassmann H, Van Horssen J, Mahad D. Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol. 2012;8(11):647–656.
   PubMed Web of Science ®Google Scholar
• Mallucci G, Peruzzotti-Jametti L, Bernstock JD, et al. The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. Prog Neurobiol. 2015;127–128:1–22.
   PubMed Web of Science ®Google Scholar
• Torkildsen Ø, Brunborg L, Myhr KM, et al. The cuprizone model for demyelination. Acta Neurol Scand. 2008;117(188):72–76.
   Google Scholar
• Yamamoto S, Gotoh M, Kawamura Y, et al. Cyclic phosphatidic acid treatment suppress cuprizone-induced demyelination and motor dysfunction in mice. Eur J Pharmacol. 2014;741:17–24.
   PubMed Web of Science ®Google Scholar
• Lucchinetti C, Brück W, Parisi J, et al. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47(6):707–717.
   PubMed Web of Science ®Google Scholar
• Liu L, Belkadi A, Darnall L, et al. CXCR2-positive neutrophils are essential for cuprizone-induced demyelination: relevance to multiple sclerosis. Nat Neurosci. 2010;13(3):319–326.
   PubMed Web of Science ®Google Scholar
• Van Horssen J, Witte ME, Schreibelt G, et al. Radical changes in multiple sclerosis pathogenesis. Biochim Biophys Acta. 2011;1812(2):141–150.
   PubMed Web of Science ®Google Scholar
• Spaas J, van Veggel L, Schepers M, et al. Oxidative stress and impaired oligodendrocyte precursor cell differentiation in neurological disorders. Cell Mol Life Sci. 2021;78(10):4615–4637.
   PubMed Web of Science ®Google Scholar
• French HM, Reid M, Mamontov P, et al. Oxidative stress disrupts oligodendrocyte maturation. J Neurosci Res. 2009;87(14):3076–3087.
   PubMed Web of Science ®Google Scholar
• Bénardais K, Kotsiari A, Škuljec J, et al. Cuprizone [bis (cyclohexylidenehydrazide)] is selectively toxic for mature oligodendrocytes. Neurotox Res. 2013;24(2):244–250.
   PubMed Web of Science ®Google Scholar
• Żukowski P, Maciejczyk M, Waszkiel D. Sources of free radicals and oxidative stress in the oral cavity. Arch Oral Biol. 2018;92:8–17.
   PubMed Web of Science ®Google Scholar
• Schieber M, Chandel NS. ROS function in redox signaling and oxidative stress. Curr Biol. 2014;24(10):R453–R462.
   PubMed Web of Science ®Google Scholar
• Limoli CL, Hartmann A, Shephard L, et al. Apoptosis, reproductive failure, and oxidative stress in Chinese hamster ovary cells with compromised genomic integrity. Cancer Res. 1998;58(16):3712–3718.
   PubMed Web of Science ®Google Scholar
• Pegoretti V, Swanson KA, Bethea JR, et al. Inflammation and oxidative stress in multiple sclerosis: consequences for therapy development. Oxid Med Cell Longev. 2020;2020. https://pubmed.ncbi.nlm.nih.gov/32454942/
   PubMed Web of Science ®Google Scholar
• Lassmann H, van Horssen J. The molecular basis of neurodegeneration in multiple sclerosis. FEBS Lett. 2011;585(23):3715–3723.
   PubMed Web of Science ®Google Scholar
• Schreibelt G, Van Horssen J, Van Rossum S, et al. Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology. Brain Res Rev. 2007;56(2):322–330.
   PubMedGoogle Scholar
• Pham-Huy LA, He H, Pham-Huy C. Free radicals, antioxidants in disease and health. Int J Biomed Sci. 2008;4(2):89–96.
   PubMedGoogle Scholar
• Kazak F, Yarim GF. Neuroprotective effects of acetyl-l-carnitine on lipopolysaccharide-induced neuroinflammation in mice: Involvement of brain-derived neurotrophic factor. Neurosci Lett. 2017;658:32–36.
   PubMed Web of Science ®Google Scholar
• Hagen TM, Liu J, Lykkesfeldt J, et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci U S A. 2002;99(4):1870–1875.
   PubMed Web of Science ®Google Scholar
• Zanelli SA, Solenski NJ, Rosenthal RE, et al. Mechanisms of ischemic neuroprotection by acetyl-L-carnitine. Ann N Y Acad Sci. 2005;1053:153–161.
   PubMed Web of Science ®Google Scholar
• Chiechio S, Copani A, Nicoletti F, et al. L-acetylcarnitine: a proposed therapeutic agent for painful peripheral neuropathies. Curr Neuropharmacol. 2006;4(3):233–237.
   PubMed Web of Science ®Google Scholar
• Vivoli E, Mannelli LDC, Salvicchi A, et al. Acetyl-L-carnitine increases artemin level and prevents neurotrophic factor alterations during neuropathy. Neuroscience. 2010;167(4):1168–1174.
   PubMed Web of Science ®Google Scholar
• Bagetta V, Barone I, Ghiglieri V, et al. Acetyl-l-carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism. Neuropharmacology. 2008;55(2):223–229.
   PubMed Web of Science ®Google Scholar
• Pennisi M, Lanza G, Cantone M, et al. Acetyl-l-carnitine in dementia and other cognitive disorders: a critical update. Nutrients. 2020;12(5):1389.
   PubMed Web of Science ®Google Scholar
• Pettegrew J, Levine J, McClure R. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol Psychiatry. 2000;5(6):616–632.
   PubMed Web of Science ®Google Scholar
• Di Stefano G, Di Lionardo A, Galosi E, et al. Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review. J Pain Res. 2019;12:1341–1351.
   PubMed Web of Science ®Google Scholar
• Tomassini V, Onesti E, Mainero C, et al. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J Neurol Neurosurg Psychiatry. 2005;76(2):272–275.
   PubMed Web of Science ®Google Scholar
• Traina G, Federighi G, Macchi M, et al. Modulation of myelin basic protein gene expression by acetyl-L-carnitine. Mol Neurobiol. 2011;44(1):1–6.
   PubMed Web of Science ®Google Scholar
• Stanley JL, Lincoln RJ, Brown TA, et al. The mouse beam walking assay offers improved sensitivity over the mouse rotarod in determining motor coordination deficits induced by benzodiazepines. J Psychopharmacol. 2005;19(3):221–227.
   PubMed Web of Science ®Google Scholar
• Skripuletz T, Miller E, Moharregh-Khiabani D, et al. Beneficial effects of minocycline on cuprizone induced cortical demyelination. Neurochem Res. 2010;35(9):1422–1433.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Franklin KB. Paxinos and Franklin’s the mouse brain in stereotaxic coordinates. Cambridge (MA): Academic Press. 2019.
   Google Scholar
• Akalιn FA, Baltacιoğlu E, Alver A, et al. Lipid peroxidation levels and total oxidant status in serum, saliva and gingival crevicular fluid in patients with chronic periodontitis. J Clin Periodontol. 2007;34(7):558–565.
   PubMed Web of Science ®Google Scholar
• Gaweł S, Wardas M, Niedworok E, et al. Malondialdehyde (MDA) as a lipid peroxidation marker. Wiad Lek. 2004;57(9–10):453–455.
   PubMedGoogle Scholar
• Razavi-Azarkhiavi K, Ali-Omrani M, Solgi R, et al. Silymarin alleviates bleomycin-induced pulmonary toxicity and lipid peroxidation in mice. Pharm Biol. 2014;52(10):1267–1271.
   PubMed Web of Science ®Google Scholar
• Ribas V, García-Ruiz C, Fernández-Checa JC. Glutathione and mitochondria. Front Pharmacol. 2014;5:151.
   PubMed Web of Science ®Google Scholar
• Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969;27(3):502–522.
   PubMed Web of Science ®Google Scholar
• Nantapong N, Murata R, Trakulnaleamsai S, et al. The effect of reactive oxygen species (ROS) and ROS-scavenging enzymes, superoxide dismutase and catalase, on the thermotolerant ability of Corynebacterium glutamicum. Appl Microbiol Biotechnol. 2019;103(13):5355–5366.
   PubMed Web of Science ®Google Scholar
• Ghahremani S, Soodi M, Atashi A. Quercetin ameliorates chlorpyrifos-induced oxidative stress in the rat brain: possible involvement of PON2 pathway. J Food Biochem. 2018;42(3):e12530.
   Web of Science ®Google Scholar
• Sachs HH, Bercury KK, Popescu DC, et al. A new model of cuprizone-mediated demyelination/remyelination. ASN Neuro. 2014;6(5):175909141455195. 1759091414551955.
   Web of Science ®Google Scholar
• Love S. Demyelinating diseases. J Clin Pathol. 2006;59(11):1151–1159.
   PubMed Web of Science ®Google Scholar
• Kremer D, Akkermann R, Küry P, et al. Current advancements in promoting remyelination in multiple sclerosis. Mult Scler. 2019;25(1):7–14.
   PubMed Web of Science ®Google Scholar
• Pancotto L, Mocelin R, Marcon M, et al. Anxiolytic and anti-stress effects of acute administration of acetyl-L-carnitine in zebrafish. PeerJ. 2018;6:e5309.
   PubMed Web of Science ®Google Scholar
• Jhelum P, Santos-Nogueira E, Teo W, et al. Ferroptosis mediates cuprizone-induced loss of oligodendrocytes and demyelination. J Neurosci. 2020;40(48):9327–9341.
   PubMed Web of Science ®Google Scholar
• Liebetanz D, Merkler D. Effects of commissural de-and remyelination on motor skill behaviour in the cuprizone mouse model of multiple sclerosis. Exp Neurol. 2006;202(1):217–224.
   PubMed Web of Science ®Google Scholar
• Calvani M, Arrigoni-Martelli E. Attenuation by acetyl-L-carnitine of neurological damage and biochemical derangement following brain ischemia and reperfusion. Int J Tissue React. 1999;21(1):1–6.
   PubMedGoogle Scholar
• Schultz V, van der Meer F, Wrzos C, et al. Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination. Glia. 2017;65(8):1350–1360.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang H, Wang L, et al. Quetiapine enhances oligodendrocyte regeneration and myelin repair after cuprizone-induced demyelination. Schizophr Res. 2012;138(1):8–17.
   PubMed Web of Science ®Google Scholar
• Simons M, Nave K-A. Oligodendrocytes: myelination and axonal support. Cold Spring Harb Perspect Biol. 2015;8(1):a020479.
   PubMed Web of Science ®Google Scholar
• Iarlori C, Gambi D, Lugaresi A, et al. Reduction of free radicals in multiple sclerosis: effect of glatiramer acetate (copaxone®). Mult Scler. 2008;14(6):739–748.
   PubMed Web of Science ®Google Scholar
• Sanoobar M, Eghtesadi S, Azimi A, et al. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing–remitting multiple sclerosis. Int J Neurosci. 2013;123(11):776–782.
   PubMed Web of Science ®Google Scholar
• Zahednasab H, Firouzi M, Kaboudanian-Ardestani S, et al. The protective effect of rifampicin on behavioral deficits, biochemical, and neuropathological changes in a cuprizone model of demyelination. Cytokine. 2019;113:417–426.
   PubMed Web of Science ®Google Scholar
• Sajad M, Zargan J, Chawla R, et al. Hippocampal neurodegeneration in experimental autoimmune encephalomyelitis (EAE): potential role of inflammation activated myeloperoxidase. Mol Cell Biochem. 2009;328(1–2):183–188.
   PubMed Web of Science ®Google Scholar
• Shiri E, Pasbakhsh P, Borhani‑Haghighi M, et al. Mesenchymal stem cells ameliorate cuprizone-induced demyelination by targeting oxidative stress and mitochondrial dysfunction. Cell Mol Neurobiol. 2021;41(7):1467–1415.
   PubMed Web of Science ®Google Scholar
• Doucette JR, Jiao R, Nazarali AJ. JCAge-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice. Cell Mol Neurobiol. 2010;30(4):607–629.
   PubMed Web of Science ®Google Scholar
• Buschmann JP, Berger K, Awad H, et al. Inflammatory response and chemokine expression in the white matter corpus callosum and gray matter cortex region during cuprizone-induced demyelination. J Mol Neurosci. 2012;48(1):66–76.
   PubMed Web of Science ®Google Scholar
• Ng DP, Deber CM. Modulation of the oligomerization of myelin proteolipid protein by transmembrane helix interaction motifs. Biochemistry. 2010;49(32):6896–6902.
   PubMed Web of Science ®Google Scholar
• Elbaz EM, Senousy MA, El-Tanbouly DM, et al. Neuroprotective effect of linagliptin against cuprizone-induced demyelination and behavioural dysfunction in mice: a pivotal role of AMPK/SIRT1 and JAK2/STAT3/NF-κB signalling pathway modulation. Toxicol Appl Pharmacol. 2018;352:153–161.
   PubMed Web of Science ®Google Scholar
• Mahad DH, Trapp BD, Lassmann H. Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol. 2015;14(2):183–193.
   PubMed Web of Science ®Google Scholar
• Denic A, Johnson AJ, Bieber AJ, et al. The relevance of animal models in multiple sclerosis research. Pathophysiology. 2011;18(1):21–29.
   PubMedGoogle Scholar